Paul Streck insider trades

Open-market stock purchases and sales by Paul Streck, EVP, Head of R&D at PepGen Inc, from SEC Form 4 filings since Jun 5, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +14%.

Recent trades

DateStockTradeValue
Mar 4, 2026PEPG PepGen IncSold$11.4K
Mar 4, 2026PEPG PepGen IncSold$296
Mar 1, 2026PEPG PepGen IncBought (not open market)—
Mar 1, 2026PEPG PepGen IncBought (not open market)—
Nov 4, 2025PEPG PepGen IncBought (not open market)—
Nov 4, 2025PEPG PepGen IncSold (not open market)—
Nov 4, 2025PEPG PepGen IncSold (not open market)—
Nov 4, 2025PEPG PepGen IncBought (not open market)—

Companies traded

  • PEPG PepGen Inc: 1 buy, 2 sales, last Mar 4, 2026
  • ALBO Albireo Pharma, Inc: other filings, last Mar 2, 2023
  • ALDR Alder Biopharmaceuticals Inc: other filings, last Oct 22, 2019
  • INSM INSMED Inc: other filings, last Aug 8, 2018

Get free alerts when Paul Streck files a new trade →